Seqirus (owned by CSL) has joined an international, non-profit venture dedicated to decoding the immune system to develop a universal flu vaccine that affords long-lasting protection against seasonal and pandemic influenza across demographics and geography. The Human Vaccines Project aims to decode the human immune system to accelerate development of vaccines and immunotherapies against major…

Read More

Last month, VIVA! Communications successfully collaborated with the Pharmacy Guild of Australia (PGA) to release new research regarding the attitudes of Australian adults toward flu vaccination. Alarmingly, it was revealed that one-in-two Australian adults do not plan to vaccinate against the flu this year. Alongside this, the research uncovered that many do not understand the…

Read More

Two days ago, VIVA! Communications teamed up the Pharmacy Guild of Australia to bring about a heightened awareness of flu vaccination, and complacency toward it, to the wider community with the release of the 2018 Flu Vaccination Study results. The Study revealed alarming statistics concerning Australian adults flu vaccination uptake and understanding. Just one-in-two Australian…

Read More

As February draws to a close, the cooler days will inevitably begin to outnumber the warmer ones. Ushered in alongside the chilly temperatures will be viruses such as the flu and rhinovirus (the common cold). At VIVA! we’re not only dedicated to inspiring healthy lifestyles through our PR work in the general community, but we’re…

Read More